"That's Their Problem": How Jared Kushner Let the Markets Decide America's COVID-19 Fate - 2020-09-17
On the evening of Saturday, March 21, a small group of Silicon Valley entrepreneurs, business executives, and venture capitalists gathered in the White House Situation Room to offer their help to the Trump administration as it confronted a harrowing shortage of lifesaving supplies to battle COVID-19.
More than seven weeks after the federal government first learned that a new and lethal coronavirus was barreling toward U.S. shores, hospitals were pleading for masks, gloves, and other personal protective equipment to safeguard their medical staff. Intensive care nurses had been photographed wearing garbage bags instead of gowns. More than 19,600 Americans had been diagnosed with the disease, and at least 260 had died.
The meeting's attendees—some present, some dialing in—were a bipartisan collection of heavy hitters. The ad hoc group had spent weeks canvassing America's private sector to map the shortages and draft a plan to solve them. Briefly using a hotel ballroom in Washington, D.C., as a makeshift headquarters, they sought answers to some urgent questions: What capacity did America's companies have to manufacture protective equipment and medical supplies? What supplies could be ordered now? Were there hidden reserves?